We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Intellectual Property Litigation: Federal Circuit May Decide Prior Art Estoppel Issue
March 15, 2019 Download PDF
Litigation partner Lew Clayton’s latest intellectual property litigation column, “Federal Circuit May Decide Art Estoppel Issue,” appeared in the March 13 issue of the New York Law Journal. The authors discuss BTG Int’l Ltd. v. Amneal Pharm., in which the Federal Circuit may decide whether §315(e)(2) acts to bar a successful inter partes review petitioner from asserting in district court the arguments that prevailed before the Patent Trial and Appeal Board. Litigation associates Michael Milea and Saurabh Gupta assisted in the preparation of this article.